Kontafarma China Holdings Limited (HKG:1312)
Hong Kong · Delayed Price · Currency is HKD 0.0280
-0.0010 (-3.45%)
Oct 30, 2026, 3:59 PM HKT
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 150.89 million as of October 30, 2026. It is the 37,072nd most valuable company in the world and the 2,030th biggest in Hong Kong. Its market cap has decreased by 6.90% in one year.
Market Cap
150.89M
Enterprise Value
181.12M
Revenue
845.33M
Global Rank
Country Rank
#2,030 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 150.89M, a decrease of -79.03%. That is a compound annual growth rate of -10.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 150.89M | -6.90% |
| Dec 31, 2025 | 162.07M | 11.54% |
| Dec 31, 2024 | 145.30M | -27.78% |
| Dec 29, 2023 | 201.19M | -20.00% |
| Dec 30, 2022 | 251.49M | -8.16% |
| Dec 31, 2021 | 273.84M | -43.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fusen Pharmaceutical Company | 761.48M |
| Lee's Pharmaceutical Holdings | 606.50M |
| Zhongzhi Pharmaceutical Holdings | 539.75M |
| Wai Yuen Tong Medicine Holdings | 401.18M |
| Regent Pacific Group | 253.88M |
| Tianda Pharmaceuticals | 191.35M |
| Shenzhen Neptunus Interlong Bio-technique Company | 186.26M |
| Extrawell Pharmaceutical Holdings | 147.90M |